GSK seeks approval for world's first malaria vaccine
LONDON (Reuters) - GlaxoSmithKline is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.
Read Full Story
Advertise Here contact ads[@]ghheadlines.com
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS